Expert consensus on the management of chronic lymphocytic leukaemia in Asia

In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Eric, Kwong, Yok Lam, Goh, Yeow Tee, Bee, Ping Chong, Ng, Soo Chin, Tan, Daryl, Caguioa, Priscilla, Nghia, Huynh, Dumagay, Teresita, Norasetthada, Lalita, Chuncharunee, Suporn, Radhakrishnan, Vivek, Bagal, Bhausaheb, Atmakusuma, Tubagus Djumhana, Mulansari, Nadia Ayu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543526/
https://www.ncbi.nlm.nih.gov/pubmed/36795237
http://dx.doi.org/10.1007/s10238-023-01007-2
_version_ 1785114314529570816
author Tse, Eric
Kwong, Yok Lam
Goh, Yeow Tee
Bee, Ping Chong
Ng, Soo Chin
Tan, Daryl
Caguioa, Priscilla
Nghia, Huynh
Dumagay, Teresita
Norasetthada, Lalita
Chuncharunee, Suporn
Radhakrishnan, Vivek
Bagal, Bhausaheb
Atmakusuma, Tubagus Djumhana
Mulansari, Nadia Ayu
author_facet Tse, Eric
Kwong, Yok Lam
Goh, Yeow Tee
Bee, Ping Chong
Ng, Soo Chin
Tan, Daryl
Caguioa, Priscilla
Nghia, Huynh
Dumagay, Teresita
Norasetthada, Lalita
Chuncharunee, Suporn
Radhakrishnan, Vivek
Bagal, Bhausaheb
Atmakusuma, Tubagus Djumhana
Mulansari, Nadia Ayu
author_sort Tse, Eric
collection PubMed
description In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL from an Asian population perspective. This consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia.
format Online
Article
Text
id pubmed-10543526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-105435262023-10-03 Expert consensus on the management of chronic lymphocytic leukaemia in Asia Tse, Eric Kwong, Yok Lam Goh, Yeow Tee Bee, Ping Chong Ng, Soo Chin Tan, Daryl Caguioa, Priscilla Nghia, Huynh Dumagay, Teresita Norasetthada, Lalita Chuncharunee, Suporn Radhakrishnan, Vivek Bagal, Bhausaheb Atmakusuma, Tubagus Djumhana Mulansari, Nadia Ayu Clin Exp Med Correspondence In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL from an Asian population perspective. This consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia. Springer International Publishing 2023-02-16 2023 /pmc/articles/PMC10543526/ /pubmed/36795237 http://dx.doi.org/10.1007/s10238-023-01007-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Tse, Eric
Kwong, Yok Lam
Goh, Yeow Tee
Bee, Ping Chong
Ng, Soo Chin
Tan, Daryl
Caguioa, Priscilla
Nghia, Huynh
Dumagay, Teresita
Norasetthada, Lalita
Chuncharunee, Suporn
Radhakrishnan, Vivek
Bagal, Bhausaheb
Atmakusuma, Tubagus Djumhana
Mulansari, Nadia Ayu
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title_full Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title_fullStr Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title_full_unstemmed Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title_short Expert consensus on the management of chronic lymphocytic leukaemia in Asia
title_sort expert consensus on the management of chronic lymphocytic leukaemia in asia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543526/
https://www.ncbi.nlm.nih.gov/pubmed/36795237
http://dx.doi.org/10.1007/s10238-023-01007-2
work_keys_str_mv AT tseeric expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT kwongyoklam expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT gohyeowtee expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT beepingchong expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT ngsoochin expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT tandaryl expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT caguioapriscilla expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT nghiahuynh expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT dumagayteresita expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT norasetthadalalita expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT chuncharuneesuporn expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT radhakrishnanvivek expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT bagalbhausaheb expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT atmakusumatubagusdjumhana expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia
AT mulansarinadiaayu expertconsensusonthemanagementofchroniclymphocyticleukaemiainasia

Ejemplares similares